HIV Pre-Immunization and Immunotherapy

Country:
US

Docket No:
436313-000200

Publication Number:
2018-0177866

Patent Expiry:
07/08/2036

Claims Scope:

Allowed.  Issue fee due March 26, 2024. 

Sequence Agnostic 

Methods of treating HIV in a subject via 

  • Immunizing the subject with an HIV vaccine,  
  • purifying PBMCs obtained from the subject,  
  • contacting the PBMCs with an HIV vaccine,  
  • transducing the PBMCs with a vector encoding,  
  • CCR5 and Tat, or 
  • Vif and Tat, or  
  • CCR5, Vif and Tat,  

followed by a culturing step and infusion step.